Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BB-613 Watch Oximeter

K-Number: K181006 · 2018-09-21

Decision Date2018-09-21
Product CodeDQA
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

BB-613 Watch Oximeter is a medical device manufactured by Bio-Beat Technologies , Ltd.. It received FDA 510(k) clearance on 2018-09-21 under approval number K181006. The device is classified under product code DQA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BB-613 Watch Oximeter?

BB-613 Watch Oximeter is a medical device that received FDA 510(k) clearance on 2018-09-21. It is manufactured by Bio-Beat Technologies , Ltd.. The 510(k) number is K181006.

When was BB-613 Watch Oximeter approved by the FDA?

BB-613 Watch Oximeter received FDA 510(k) clearance on 2018-09-21, under approval number K181006.

What company makes BB-613 Watch Oximeter?

BB-613 Watch Oximeter is manufactured by Bio-Beat Technologies , Ltd..

What is the FDA product code for BB-613 Watch Oximeter?

The FDA product code for BB-613 Watch Oximeter is DQA.

Related Devices (Code: DQA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.